Accumulation of β- and γ-synucleins in the ubiquitin carboxyl-terminal hydrolase L1-deficient gad mouse

Abstract The synuclein family includes three isoforms, termed α, β and γ. α-Synuclein accumulates in various pathological lesions resulting from neurodegenerative disorders including Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy. However, neither β- nor γ-synuclein has been detected in Lewy bodies, and thus it is unclear whether these isoforms contribute to neurological pathology. In the present study, we used immunohistochemistry to demonstrate accelerated accumulation of β- and γ-synucleins in axonal spheroids in gracile axonal dystrophy ( gad ) mice, which do not express ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1). γ-Synuclein immunoreactivity in the spheroids appeared in the gracile nucleus at 3 weeks of age and was maintained until 32 weeks. β-Synuclein immunoreactivity appeared in spheroids around 12 weeks of age. In contrast, α-synuclein immunoreactivity was barely detectable in spheroids. Immunoreactivity for synaptophysin and ubiquitin were either faint or undetectable in spheroids. Given that UCH-L1 deficiency results in axonal degeneration and spheroid formation, our findings suggest that β- and γ-synuclein participate in the pathogenesis of axonal swelling in gad mice.

[1]  Edward J. Dick,et al.  Expression of stress proteins alpha B-crystallin, ubiquitin, and hsp27 in pallido-nigral spheroids of aged rhesus monkeys , 2001, Neurobiology of Aging.

[2]  H Shibasaki,et al.  Progressive degeneration of motor nerve terminals in GAD mutant mouse with hereditary sensory axonopathy , 1993, Neuropathology and applied neurobiology.

[3]  D. Price,et al.  Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Sidman,et al.  Atlas of the Mouse Brain and Spinal Cord , 1971 .

[5]  P. Mcgeer,et al.  Two Types of Spheroid Bodies in the Nigral Neurons in Parkinson's Disease , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[6]  J Q Trojanowski,et al.  Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  John Q. Trojanowski,et al.  Ubiquitination of α-Synuclein Is Not Required for Formation of Pathological Inclusions in α-Synucleinopathies , 2003 .

[8]  J. Trojanowski,et al.  Neurodegeneration with Brain Iron Accumulation, Type 1 Is Characterized by α-, β-, and γ-Synuclein Neuropathology , 2000 .

[9]  T. Tomita,et al.  Neuropathology of gracile axonal dystrophy (GAD) mouse , 1989, Acta Neuropathologica.

[10]  Kaori Nishikawa,et al.  Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. , 2003, Human molecular genetics.

[11]  Jimi Adu,et al.  Persyn, a member of the synuclein family, influences neurofilament network integrity , 1998, Nature Neuroscience.

[12]  J. Vickers,et al.  Localization of α-, β-, and γ-synuclein during neuronal development and alterations associated with the neuronal response to axonal trauma , 2003, Experimental Neurology.

[13]  A. Bizzi,et al.  Axonal transport of two major components of the ubiquitin system: free ubiquitin and ubiquitin carboxyl-terminal hydrolase PGP 9.5 , 1991, Brain Research.

[14]  Takayuki Harada,et al.  Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice , 1999, Nature Genetics.

[15]  K. Suzuki,et al.  Pathological study of mice with total deficiency of sphingolipid activator proteins (SAP knockout mice) , 1998, Acta Neuropathologica.

[16]  Matthew J. Farrer,et al.  Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications , 2004 .

[17]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[18]  Substance P-like immunoreactivity in the gracile nucleus and fasciculus in old mice , 1989, Neuroscience Letters.

[19]  T. Iwanaga,et al.  Expression of protein gene product 9.5, a neuronal ubiquitin C‐terminal hydrolase, and its developing change in Sertoli cells of mouse testis , 1999, Molecular reproduction and development.

[20]  W. Honer,et al.  Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. , 1998, The American journal of pathology.

[21]  Makoto Hashimoto,et al.  β-Synuclein Inhibits α-Synuclein Aggregation A Possible Role as an Anti-Parkinsonian Factor , 2001, Neuron.

[22]  C. Larsen,et al.  Comparisons of neuronal (PGP 9.5) and non-neuronal ubiquitin C-terminal hydrolases. , 1992, Biochemical Society transactions.

[23]  T. Hirokawa,et al.  Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. , 2003, Biochemical and biophysical research communications.

[24]  T. Kikuchi,et al.  Axonal degeneration of ascending sensory neurons in gracile axonal dystrophy mutant mouse , 2004, Acta Neuropathologica.

[25]  J Q Trojanowski,et al.  Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein , 1998, Annals of neurology.

[26]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[27]  Y. Imai,et al.  Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity* , 2000, The Journal of Biological Chemistry.

[28]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[29]  T. Tomita,et al.  Gracile Axonal Dystrophy (GAD), a New Neurological Mutant in the Mouse , 1988, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[30]  J. Lowe,et al.  Ubiquitin carboxyl‐terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases , 1990, The Journal of pathology.

[31]  T. Yokoyama,et al.  Neuropathology of chronic vitamine E deficiency in fatal familial intrahepatic cholestasis , 2004, Acta Neuropathologica.

[32]  A. Davies,et al.  Persyn, a Member of the Synuclein Family, Has a Distinct Pattern of Expression in the Developing Nervous System , 1998, The Journal of Neuroscience.

[33]  T. Kikuchi,et al.  AXONAL DEGENERATION IN THE CENTRAL NERVOUS SYSTEM OF GRACILE AXONAL DYSTROPHY (GAD) MICE PROGRESSES LIKE IN HUMAN SPINOCEREBELLAR ATAXIAS , 1991 .

[34]  A. Gregory,et al.  Neurodegeneration with brain iron accumulation. , 2005, Folia neuropathologica.

[35]  N. Ichihara,et al.  Axonal degeneration promotes abnormal accumulation of amyloid β-protein in ascending gracile tract of gracile axonal dystrophy (GAD) mouse , 1995, Brain Research.

[36]  P. Lansbury,et al.  The UCH-L1 Gene Encodes Two Opposing Enzymatic Activities that Affect α-Synuclein Degradation and Parkinson's Disease Susceptibility , 2002, Cell.

[37]  E. Masliah,et al.  C-terminal α-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders , 2000, Acta Neuropathologica.

[38]  H. Braak,et al.  Pallido-nigral spheroids in nonhuman primates: accumulation of heat shock proteins in astroglial processes , 2002, Acta Neuropathologica.

[39]  M. Goedert,et al.  Lewy body diseases and multiple system atrophy as α-synucleinopathies , 1998, Molecular Psychiatry.

[40]  W. Halliday.  The nosology of Hallervorden-Spatz disease , 1995, Journal of the Neurological Sciences.

[41]  N. Arai.  Grumose or foamy spheroid bodies involving astrocytes in the human brain , 1995, Neuropathology and applied neurobiology.

[42]  A. Dehejia,et al.  Identification, localization and characterization of the human γ-synuclein gene , 1998, Human Genetics.

[43]  J. Aicardi,et al.  Infantile neuroaxonal dystrophy. , 1979, Brain : a journal of neurology.